Cardiac Science Corporation, a group company of Opto Circuits (India) announced that its Powerheart G5 AED has received 510(k) market clearance from the USFDA (Food and Drug Administration), allowing the company to begin selling the AED later this year along with Powerheart G3 product line.

'This news is a testament to the commitment shown by our employees who have spent many years of developing, testing and refining the Powerheart G5 so that seasoned and first-time resucers will have the most reliable, easy-to-use AED in the US marketplace,’’ said Vinod Ramnani, chairman and managing director, Opto Circuits (India). 'Our product portfoilio is now the envy of the AED industry.'

Shares of the company gained Rs 1, or 3.97%, to trade at Rs 26.20. The total volume of shares traded was 739,294 at the BSE (2.37 p.m., Thursday).